Rivaroxaban, a direct factor Xa inhibitor, ameliorates angiotensin II-induced renal damage through inhibition of protease-activated receptor pathway-mediated inflammatory response
Event:
ESC Congress 2017
Topic:
Basic Science
Session:
Cardiovascular care - Biology II